Thetford Mines, Quebec – November 18, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the Corporation has signed an exclusive Letter of Intent (the “LOI”) with ZoomMed Medical Inc. (“ZoomMed Medical”) for the acquisition of the ZRx Prescriber technology asset consisting of its platform and source codes (the “ZRx Prescriber Asset”). KDA aims to develop and use the ZRx Prescriber Asset in the United States and Europe.

Thetford Mines, Quebec – October 21, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the appointment of Mr. Jean-Pierre Robert as Chief Operating Officer of KDA, this appointment being effective immediately.

Thetford Mines, Quebec – October 16, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it proposed to amend the expiry date of 13,890,333 warrants to purchase 13,890,333 Class A Shares of KDA (the “Common shares”) at a price of $0.20 per Common share from November 7, 2020 to November 7, 2021 as permitted under the TSX Venture Exchange (“TSXV”) Policy.

Thetford Mines, Quebec – October 15, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce today the appointments of Mr. Sylvain Duvernay as Chief Executive Officer of KDA and Mr. Pierre Monet as Chief Financial Officer of the Corporation, effective immediately.

Thetford Mines, Quebec – October 14, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the expansion of a new division in the dental care field for the province of Quebec.

Thetford Mines, Quebec – September 29, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it proposed to amend the expiry date of 9,860,000 warrants to purchase 9,860,000 Class A shares of KDA (the “Common shares”) at a price of $0.40 per Common share from October 22, 2020 to October 22, 2022 as permitted under the TSX Venture Exchange (“TSXV”) Policy.

Thetford Mines, Quebec – September 9, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to provide an update on its technological platforms in the cannabis field for medical purposes (the “Elixir420”) previously announced in its press release dated April 9, 2020.

Thetford Mines, Quebec – July 15, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that the Corporation has signed an exclusive letter of intent (the “Letter of Intent”) with ID Solution Inc. (“ID Solution”) for the sale and distribution of screening technology products (the “Products”) in the field of medical safety and security for pharmacies, laboratories, nursing homes, hospitals, clinics and any other building for the Canadian market in the healthcare sector. These Products are of particular interest during these times of pandemic associated to COVID-19.

Thetford Mines, Quebec – July 13, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce the addition of Mr. Anthony Rail as a member of its strategic advisory board (the “Strategic Board”). “We are proud that Mr.

Thetford Mines, Quebec – July 2, 2020 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) announces that it intends to rely on blanket exemptions issued by provincial securities commissions due to the COVID-19 outbreak that permit the Company to extend the filing deadline of certain continuous disclosure documents for a period of up to 45 days.